SMTL ID : 7wos.1

The state 3 of Omicron Spike with bispecific antibody FD01

Coordinates

PDB Format

Method

ELECTRON MICROSCOPY

Oligo State

hetero-3-2-2-mer

Ligands

21 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.1: 3 residues within 4Å: Chain A: N.706, N.707 Chain C: Y.793 Ligand excluded by PLIP NAG.2: 2 residues within 4Å: Chain A: T.713, N.714 Ligand excluded by PLIP NAG.3: 2 residues within 4Å: Chain A: N.798, S.800 Ligand excluded by PLIP NAG.4: 4 residues within 4Å: Chain A: N.1095, T.1097, H.1098, F.1100 Ligand excluded by PLIP NAG.5: 3 residues within 4Å: Chain A: I.1129, V.1130, N.1131 Ligand excluded by PLIP NAG.6: 5 residues within 4Å: Chain B: Q.113, E.130, N.160, C.161, T.162 Ligand excluded by PLIP NAG.7: 3 residues within 4Å: Chain B: E.278, N.279 Chain C: K.555 Ligand excluded by PLIP NAG.8: 5 residues within 4Å: Chain B: N.328, P.576, Q.577, T.578, L.579 Ligand excluded by PLIP NAG.9: 3 residues within 4Å: Chain B: N.613, T.615, Q.641 Ligand excluded by PLIP NAG.10: 3 residues within 4Å: Chain A: Y.793 Chain B: S.705, N.706 Ligand excluded by PLIP NAG.11: 4 residues within 4Å: Chain B: T.713, N.714, L.919, Q.1068 Ligand excluded by PLIP NAG.12: 3 residues within 4Å: Chain B: N.798, S.800, Q.801 Ligand excluded by PLIP NAG.13: 4 residues within 4Å: Chain B: N.1095, T.1097, H.1098, F.1100 Ligand excluded by PLIP NAG.14: 2 residues within 4Å: Chain B: I.1129, N.1131 Ligand excluded by PLIP NAG.15: 3 residues within 4Å: Chain C: N.277, E.278, N.279 Ligand excluded by PLIP NAG.16: 4 residues within 4Å: Chain C: N.328, P.576, Q.577, T.578 Ligand excluded by PLIP NAG.17: 4 residues within 4Å: Chain B: I.791, Y.793 Chain C: Y.704, N.706 Ligand excluded by PLIP NAG.18: 4 residues within 4Å: Chain C: T.713, N.714, L.919, Q.1068 Ligand excluded by PLIP NAG.19: 3 residues within 4Å: Chain C: N.798, S.800, Q.801 Ligand excluded by PLIP NAG.20: 4 residues within 4Å: Chain C: N.1095, T.1097, H.1098, F.1100 Ligand excluded by PLIP NAG.21: 1 residues within 4Å: Chain C: N.1131 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wang, Y. et al., Combating the SARS-CoV-2 Omicron (BA.1) and BA.2 with potent bispecific antibodies engineered from non-Omicron neutralizing antibodies. Cell Discov (2022)

Release Date

2022-11-30

Peptides

Spike glycoprotein: ABC
16L9 Fv: DF
GW01 Fv: EG

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

D
D

F
F

E
E

G
G

Spike glycoprotein

16L9 Fv

GW01 Fv

Related Entries With Identical Sequence